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Summary
Objectives: The objectives of this study were to identify the causative microorganisms and
factors associated with survival in patients with Fournier’s gangrene and to determine the
accuracy of the Fournier’s gangrene severity index.
Materials and methods: We retrospectively evaluated 27 patients with Fournier’s gangrene who
were treated and followed up at our hospital between January 2005 and December 2006.
Biochemical, hematologic, and bacteriologic study results at admission and at the final evalua-
tion, etiologic and predisposing factors at admission, physical examination findings, the timing
and extent of surgical debridement, and antibiotic therapy used were all recorded.
Results: The admission laboratory parameters that were significantly correlated with outcome
included urea, creatinine, sodium, and potassium; at the final evaluation, in addition to these
parameters, hematocrit, albumin, and bicarbonate levels were also significantly associated with
outcome. The mean Fournier’s gangrene severity index score (FGSIS) at admission for survivors
was 5.04  2.49 compared with 13.6  4.61 for non-survivors. There was a strong correlation
between the FGSIS and mortality ( p < 0.0001). Escherichia coli and Pseudomonas aeruginosa
were the most commonly isolated microorganisms.
Conclusions: Patient metabolic status and predisposing factors are important in the prognosis of
Fournier’s gangrene. Hence, we believe that the FGSIS should be used clinically to evaluate
therapeutic options and assess results.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author.
E-mail address: egedik@dicle.edu.tr (E. Gedik).
1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.01.021Introduction
Fournier’s gangrene (FG) is a life-threatening necrotizing
fasciitis of the perineal, genital and perianal region, which
leads to thrombosis of the small subcutaneous vessels andPublished by Elsevier Ltd. All rights reserved.
Microbiology and Fournier s gangrene severity index e425results in the development of gangrene of the overlying skin.1
FG was first described in 1883 by Jean Alfred Fournier, who
was a French venereologist. Fournier concluded that three
findings characterize the syndrome: abrupt onset in a healthy
young man, rapid progression, and the absence of a specific
causative agent.2,3 In cases originating in the genitalia, the
infecting bacteria probably pass through Buck’s fascia of the
penis and spread along the Dartos fascia of the scrotum and
penis, Colles’ fascia of the perineum, and Scarpa’s fascia of
the anterior abdominal wall.4
Despite advancements in knowledge regarding the etiol-
ogy, diagnosis, modern intensive care techniques, and med-
ical therapy of FG, the mortality rate remains high at
between 0% and 67%.2,5,6 Although conservative treatment
without surgery may suffice in some cases, FG remains a
surgical emergency, and early recognition and prompt radical
debridement are the mainstays of management.
It is believed that systemic conditions such as age, dia-
betes mellitus, alcoholism, paralysis or neurological deficit,
malignancy, debility, and immunosuppression predispose to
the development of this entity.7,8
In published reports, the factors affecting survival or death
fromFGwerenot clearly identifieduntil the studyof Laor et al.
in 1995, in which measurable pathophysiologic data between
survivors and non-survivors of FG were compared.9
We reviewed our experience of 27 patients treated for FG
to identify the factors affecting survival and themicrobiology
of the disease.
Materials and methods
The medical records of 27 consecutive patients with FG, who
were treated and followed up at the departments of General
Surgery and Infectious Diseases and Clinic Microbiology, Dicle
University Hospital, Diyarbakır, Turkey, between January
2005 and December 2006, were reviewed retrospectively.
Clinical diagnoses were based on general appearance,
medical history, physical examination, laboratory data, and
signs and symptoms upon admission. Biochemical, hematolo-
gic, and bacteriologic study results at admission and at the
final evaluation, etiologic and predisposing factors at admis-
sion, physical examination findings, the timing and extent of
surgical debridement, and antibiotic therapy used were all
recorded. The admission timewas defined as the time interval
from the onset of symptoms to hospital admission.
The extent of gangrene was calculated for a modified body
surface area in nomograms routinely used to assess the extent
of burn injuries: the penis, scrotum, and perineum accounted
for 1% surface area, the ischiorectal fossa for 2.5%, etc.
All culture samples were transported without delay to our
clinical laboratory. The material was routinely streaked onto
eosin—methylene blue agar and 5% sheep blood agar. The two
plates were incubated in air at 37 8C for 24 hours for aerobic
microorganisms. Further eosin—methylene blue agar and 5%
sheep blood agar plates were sealed into Ziploc plastic bags to
maintain an increased CO2 atmosphere at 37 8C for 24—
72 hours for anaerobicmicroorganisms.Beforethe resultswere
obtained, a wide range of antibiotherapy was started empiri-
cally in combinations of penicillin G, third-generation cepha-
losporin, especially ceftriaxone, and metronidazole intraven-
ously, according to the general condition of the patient. These
regimens were changed on the basis of sensitivity tests.All patients underwent early, aggressive surgical debride-
ment, and additional debridements were performed when
necessary. For those who survived, no additional procedures
were needed, and the wounds were followed up for second-
ary healing.
The Fournier’s gangrene severity index (FGSI), which was
created bymodifying the acute physiology and chronic health
evaluation II severity score (APACHE II) by Laor et al. in 1995,
was used in our study.9 The index was developed in an
attempt to assign a numerical score that describes the
severity of the FG. In the FGSI, nine parameters are mea-
sured, and the degree of deviation from normal is graded
from 0 to 4. The individual values are summed to reach the
FGSI score (FGSIS). These parameters are temperature, heart
rate, respiratory rate, serum sodium, potassium, creatinine,
and bicarbonate levels, hematocrit, and leukocyte count
(Table 1). The data were assessed according to whether
the patient survived or not.
Statistical analysis was performed with SPSS for Windows,
version 11.0 (SPSS Inc., Chicago, IL, USA). All data were
analyzed by the Mann—Whitney U-test. The admission and
final evaluation parameters for each groupwere compared by
Wilcoxon signed-rank test. p-Values of less than 0.05 were
considered statistically significant.
Results
The mean age of patients who survived was 53.95  21.49
(range 19—88) years and for non-survivors was 57.20  12.94
(range 38—73) years (Figure 1 and Table 2). The difference in
age between survivors and non-survivors was not significant
( p = 0.050, U = 24 000). Of the patients, 20 (74.1%) were men
and seven (25.9%) were women, and two of the non-survivors
were women. Of the 27 patients studied, 22 survived and five
died; the overall mortality rate was 18.5%.
Presenting symptoms included erythema in 27 patients
(100%), perianal/scrotal swelling in 23 patients (85.1%),
perianal/scrotal pain in 21 patients (77.8%), purulence or
wound discharge in 19 patients (70.4%), and fever in 12
patients (44.4%).
The median extent of the body surface area involved in
the necrotizing process in patients who survived was 2.29%
and in patients who did not survive was 3.4% ( p = 0.084,
U = 28 000). The difference in median admission time was not
significant between survivors and non-survivors; it was
6.68  3.73 (range 2—15) days for survivors and 5.4  3.43
(range 2—10) days for non-survivors ( p = 0.395, U = 41 500).
All patients underwent radical surgical debridement with
excision of all necrotic material and tissue of doubtful via-
bility. The number of surgical debridements did not seem to
influence patient outcome; it was performed a mean of 1.59
times in patients who survived compared to 1.4 times in
patients who subsequently died. This difference was not
statistically significant ( p = 0.599, U = 47 500).
The laboratory parameters measured at admission and at
final evaluation are given in Table 2, and included the white
blood cell count, hematocrit, platelet count, and serum
urea, creatinine, sodium, potassium, alkaline phosphatase,
albumin, lactate dehydrogenase, cholesterol, and bicarbo-
nate levels. With the exception of serum urea, creatinine,
sodium, and potassium levels, no significant difference was
found between survivors and non-survivors at admission
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Figure 1 Relationship between age and mortality.
e426 M. Ulug˘ et al.( p = 0.002, p = 0.003, p = 0.001, p = 0.001, respectively). As
can be seen in Table 2, the statistically significant parameters
for a bad prognosis and death were as follows: serum urea,
creatinine, sodium, and potassium levels at admission and at
final evaluation.
Predisposing factors found in 25 patients included perianal
disease (n = 15, 60%), diabetes mellitus (DM; n = 14, 56%),
congestive heart failure (n = 4, 16%), hypertension (n = 3,
12%), chronic renal failure (n = 1, 4%), and malignancy
(n = 1, 4%). Predisposing factors could not be identified in
the remaining two patients. Etiologic factors for mortality in
our patients were sepsis (n = 2) and congestive heart failure
(n = 1); in two patients no specific etiology could be identi-
fied.
The mean duration of hospitalization was 31.54  15.15
(range 14—68) days for survivors and 12.8  14 (range 4—37)
days for non-survivors.
Various organisms, alone or in combination, were grown
from wound or excised tissue material. In our study Escher-
ichia coli (n = 16, 51.6%) and Pseudomonas aeruginosa (n = 4,
12.9%) were the most commonly isolated bacteria. The other
organisms isolated were Staphylococcus aureus, Enterobac-
ter cloacae, Streptococcus pyogenes, Providencia rustigia-
nii, and Bacteroides species. Results of bacteriologic culture
are presented in Table 3; four patients were infected with
multiple species. All blood cultures were negative except for
that of one non-survivor patient, from which E. coli was
yielded. However, we found that outcome was not related
to any specific bacterial species.
The mean admission FGSIS was 5.04  2.49 (range 0—9)
for survivors and 13.6  4.61 (range 10—20) for non-survi-
vors ( p = 0.001); however, themean FGSIS at final evaluation
was 1.45  0.47 (range 0—4) for survivors and 12.2  1.3
(range 11—14) for non-survivors ( p < 0.0001). The healing
rate in the survivor group demonstrates that the FGSIS might
be a useful method for evaluating therapeutic options
(Figure 2).
Discussion
Fournier’s gangrene, a rarely seen synergistic infection ori-
ginating from the colorectal and genito-urinary systems,
Table 2 Parameters evaluated at admission and at the final evaluation for survivors and non-survivors
Variable Survivors (n = 22) (min/max) Non-survivors (n = 5) (min/max) p- and U-values
Age (years) 53.95  21.49 (19—88) 57.20  12.94 (38—73) p = 0.05; U = 24 000
Admission time (days) 6.68  3.73 (2—15) 5.4  3.43 (2—10) p = 0.395; U = 41 500
Body surface (%) 2.29  1.16 (1—4.5) 3.4  1.08 (2—4.5) p = 0.084; U = 28 000
Number of debridements 1.59  0.66 (1—3) 1.4  0.54 (1—2) p = 0.599; U = 47 500
Urea (mg/dl)
Admission 55.59  49.8 (19—246) 83.6  46.17 (37—158) p = 0.002; U = 6000
Final 34.95  20.9 (18—115) 72.8  20.68 (44—101) p = 0.003; U = 7500
Creatinine (mg/dl)
Admission 0.7  0.35 (0.1—1.52) 2.29  1.92 (0.9—5.62) p = 0.003; U = 8000
Final 0.8  0.26 (0.4—1.7) 1.48  0.69 (0.9—1.71) p = 0.003; U = 8500
Sodium (mmol/l)
Admission 131.4  5.07 (119—142) 126  5.78 (120—135) p = 0.001; U = 3500
Final 135.95  4.29 (128—144) 132  5.09 (129—141) p = 0.001; U = 2000
Potassium (mmol/l)
Admission 4.1  0.2 (3.8—4.4) 3.61  0.1 (3.4—3.9) p = 0.001; U = 4000
Final 4.08  0.33 (3.6—4.8) 3.16  0.28 (2.8—3.6) p = 0.001; U = 1000
ALP (U/l)
Admission 284.81  135.99 (86—550) 278.8  31.05 (247—321) p = 0.779; U = 50 500
Final 241.86  102.28 (123—550) 253.6  60.26 (157—321) p = 0.435; U = 42 500
Albumin (g/dl)
Admission 2.32  0.73 (1—3.9) 1.76  0.63 (1.1—2.4) p = 0.261; U = 37 000
Final 3.21  0.74 (1.89—4.3) 2.1  0.25 (1.8—2.4) p = 0.010; U = 14 000
LDH (U/l)
Admission 407.9  122.99 (219—745) 472.4  158.86 (291—684) p = 0.454; U = 43 000
Final 326.77  68.74 (256—547) 338  81.57 (264—464) p = 0.803; U = 51 000
Bicarbonate (mmol/l)
Admission 21.39  3.44 (15.4—27.1) 18.2  3.97 (14—23.4) p = 0.111; U = 29 500
Final 24.64  1.81 (21—28) 18.58  2.27 (16—21) p = 0.001; U = 500
Cholesterol (mg/dl)
Admission 188.4  27.44 (134—241) 176.2  28.41 (140—210) p = 0.492; U = 44 000
Final 175.4  24.58 (134—241) 176.4  24.13 (145—201) p = 0.876; U = 52 500
WBC (109/l)
Admission 16.719  51.228 (6.390—26.100) 21.420  12.122 (11.300—41.400) p = 0.492; U = 44 000
Final 10.718  21.277 (7.800—15.200) 16.560  74.393 (8.700—28.300) p = 0.061; U = 25 000
Hematocrit (g/dl)
Admission 34.05  6.84 (22.5—47.1) 30.46  5.75 (22.4—38.2) p = 0.303; U = 38 500
Final 35.96  4.25 (29—44.5) 27.92  2.26 (24.6—31) p = 0.001; U = 3000
Platelet count (109/l)
Admission 285.27  104.12 (102—470) 225.6  123.75 (65—345) p = 0.532; U = 45 000
Final 289.54  74.79 (156—410) 246.2  100.93 (101—352) p = 0.618; U = 47 000
FGSIS
Admission 5.04  2.49 (0—9) 13.6  4.61 (10—20) p = 0.001; U = 000
Final 1.45  0.47 (0—4) 12.2  1.3 (11—14) p = 0.0001; U = 000
ALP, alkaline phosphatase; LDH, lactate dehydrogenase; WBC, white blood cell count; FGSIS, Fournier’s gangrene severity index score.
Microbiology and Fournier s gangrene severity index e427begins in the perineal, perianal and genital regions and
extends rapidly.2,10
In published studies, the median age of patients with FG
has been found to be between 46.5 and 63.5 years.7,11 In our
study, we found it to be 54.5 years, similar to Spirnak et al.12
in 1984; they also found no statistically significant difference
in age between survivors and non-survivors. In contrast,Clayton et al.13 found that survivors were significantly
younger than non-survivors, and this was confirmed by Laor
et al.9
The clinical presentation of the disease starts with a
prodromal period of genital discomfort or pruritis, followed
by genital erythema with or without crepitus and swelling of
the scrotum, often associated with fever and pain. The
Table 3 Bacterial organisms isolated from wound cultures of patients with Fournier’s gangrene
Organisms Total number Survivors Non-survivors
Escherichia coli 16 12 4
Staphylococcus aureus 3
MRSA 1 0 1
MSSA 2 2 0
Streptococcus pyogenes 2 1 1
Pseudomonas aeruginosa 4 2 2
Enterobacter cloacae 3 3 0
Bacteroides spp 2 1 1
Providencia rustigianii 1 1 0
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus.
Figure 2 Comparison of Fournier’s gangrene severity index
score (FGSIS) in survivors and non-survivors.
e428 M. Ulug˘ et al.gangrenous process will lead to drainage of the affected
areas and demarcation between viable and dead tissue.14
In our study most of the patients were admitted with com-
plaints of erythema, perianal or scrotal swelling, pain, and
fever. It is important to recognize that patients in the early
stages can present with minimal cutaneous manifestations of
the underlying infection, making prompt diagnosis difficult.
Several symptoms and signs should increase the index of
suspicion for a necrotizing subcutaneous infection. For exam-Table 4 Comparison of Fournier’s gangrene mortality rate in the
Study (Ref.) Survivors (n)
Ulug˘ et al., present report 22
Kılıc et al. (3) 19
Tuncel et al. (11) 14
Ersay et al. (7) 54
Ayan et al. (10) 32
Tahmaz et al. (15) 31
Korkut et al. (16) 36
Yeniyol et al. (14) 19ple, an apparent cellulitis that does not respond to appro-
priate antibiotic therapy should raise a suspicion of FG.15
Despite the development of modern intensive care tech-
niques, aggressive debridements, improved wound care, and
extensive antibiotic regimens, the reported mortality rates
for FG range from 0% to 67%.2,5,6 FG mortality rates found in
Turkey are shown in Table 4.3,7,10,11,14—16 In the present study,
our mortality rate was 18.5%. This high mortality reflects
both the aggressive nature of the infection and the destruc-
tive effect of accompanying predisposing factors.7 Severe
sepsis, coagulopathy, acute kidney failure, diabetic ketoaci-
dosis, andmultiple organ failure are reported as the causes of
death in patients with FG. These conditions predispose to
septicemia and increasing ischemia by disturbance of the
microcirculation, and facilitate advanced circulatory distur-
bances.2,11 In our study, DM and perianal disease were the
most common predisposing factors, and 54.5% of the survi-
vors and 40% of the non-survivors had DM. Although DM did
not affect the outcome in some studies,9,14 our study indi-
cates that patients with DM are more susceptible to FG.
Surgical management includes the wide incision and drai-
nage of all involved areas and the excision of all necrotic and
devitalized skin and subcutaneous tissue.3,12 Aggressive sur-
gical debridements always suggest a positive effect on sur-
vival.9,12,17 In this study, we found that the number of
debridements was not significantly different between survi-
vors and non-survivors. Laor et al.9 and Palmer et al.18 also
found that repeated surgical debridements did not appear to
influence patient outcome. We found that the extent of body
surface area involved in the necrotizing process was also not
directly related to outcome. This is similar to the findings of
Laor et al.9 and Clayton et al.13, but not to the findings of
others.11,12,14,19present study and others from Turkey
Non-survivors (n) Mortality rate (%)
5 18.5
4 17.4
6 30
16 22.8
9 21.9
2 6
9 20
6 24
Microbiology and Fournier s gangrene severity index e429In our study, when we compared the laboratory values at
admission between survivors and non-survivors (Table 2),
serum urea, creatinine, sodium, and potassium levels were
significantly different. With the exception of these para-
meters, no other significant differences were observed
between the two groups. Serum urea, creatinine, sodium,
potassium, albumin, and bicarbonate levels, and hematocrit
were significantly different at the final evaluation. Non-survi-
vors had greater serum urea and creatinine levels, and lower
sodium, potassium, albumin, and bicarbonate levels and lower
hematocrit at the final evaluation. In other studies, such as
that of Clayton et al.,13 only blood urea nitrogen >50 mg/dl
was found tobe statistically significant formortalityamongthe
parameters studied. Laor et al.9 reported that patients who
survived had significantly greater hematocrit, serum calcium,
albumin and cholesterol levels and lower blood urea nitrogen
and alkaline phosphatase levels compared with the admission
laboratory results. Yeniyol et al.14 found that lower serum
albumin and total protein levels were directly related to
mortality. On the other hand Tuncel et al.11 stated that
admission serum biochemical and hematologic parameters
do not always reflect severity of the disease. In the light of
our results, we found that patients who did not have renal
dysfunction at admission were those who survived.
FG begins as an area of infection adjacent to the portal of
entry. The infection then progresses to a spreading inflam-
matory reaction that involves the deep fascial planes. There
is a characteristic obliterative endarteritis causing cutaneous
and subcutaneous vascular thrombosis and necrosis of tissue.
This in turn allows the commensal flora to enter previously
sterile areas. Tissue destruction then results from a combi-
nation of ischemia and the synergistic action of various
bacteria.1,3,15 FG represents a polymicrobial infection,
although not all implicated organisms are necessarily cul-
tured in individual cases. Both aerobes and anaerobes are
almost invariably present, but anaerobes are less frequently
isolated.17 Blood cultures are usually negative. Overall, the
most commonly isolated species are Enterobacteriaceae,
especially E. coli, followed by streptococcal species; staphy-
lococci, P. aeruginosa, peptostreptococci, Bacteroides spp,
and clostridia are also frequently identified.9,15 These organ-
isms are present in the normal flora of the gastrointestinalTable 5 Comparison of microorganisms isolated from patients in
Etiological agent Ulug˘ et al.,
present report
Ersay et al. 7 Aya
Escherichia coli 16 (51.6) 28 (17.3) 24 (
Staphylococcus spp 3 (9.7) 18 (11.1) 15 (
Pseudomonas aeruginosa 4 (12.9) 17 (10.5) 2 (
Streptococcus spp 2 (6.4) 26 (16.0) 6 (
Enterobacter cloacae 3 (9.7) - -
Bacteroides spp 2 (6.4) 27 (16.7) 3 (
Proteus spp - 13 (8.0) 2 (
Clostridium spp - - 3 (
Enterococcus spp - 19 (11.7) -
Klebsiella spp - 14 (8.6) -
Acinetobacter spp - - -
Peptostreptococcus - - -
Providencia rustigianii 1 (3.2) - -
Results are n (%).tract and perineum. Paty and Smith20 reported E. coli,
Bacteroides and streptococci to be the most common organ-
isms in FG. Laor et al.9 determined the most common organ-
isms to be E. coli and Streptococcus species with
Staphylococcus and Enterococcus more commonly isolated
than Bacteroides. In the present study, similar common
bacteriologic agents, such as E. coli, Staphylococcus and
Bacteroides were isolated in wound cultures from the
patients. Chawla et al.21 stated that if the results of wound
culture revealed viridans streptococci, the patients had a
longer duration of hospital stay, but this was not significant in
our study. Although we isolated few anaerobic organisms,
their presence was strongly suspected based on crepitus and
subcutaneous emphysema. A comparison of the microorgan-
isms isolated from the patients in our study and from other
studies in Turkey is shown in Table 5.3,7,10,11,15
The treatment of FG is immediate extensive debridement
and a combination of antibiotics, along with treatment of the
predisposing conditions. After surgical resection, daily
wound care needs to be carried out to fight local infection.
A combination of antibiotics targeting all three of the main
bacterial groups must be used. Many studies have suggested
the use of penicillin against streptococci, metronidazole for
anaerobes, and third-generation cephalosporins against sta-
phylococci and Enterobacteriaceae.2,5,6 Aminoglycosides,
clindamycin, and chloramphenicol are the antibiotics of
choice until the results of culture antibiograms are obtained.
If the presence of clostridia is suspected, intravenous peni-
cillin G must be administered.
The FGSI was created by Laor et al.,9 and in their study the
mean FGSIS for survivors was 6.9 and for non-survivors was
13.5. This difference was statistically significant. They found
that when a FGSIS of 9 was used as the threshold parameter to
predict outcome, those with a score >9 had a 75% probability
of death, and an index score of 9 was associated with a 78%
probability of survival. Chawla et al.21 reported that the FGSI
indicated the likelihood of survival based on variables that
could be recorded upon presentation and also provided an
efficient way to characterize the severity of presentation and
to compare patients. In our study, the mean index score had
100% correlation for survivors and those who died compared
with the threshold parameter of 9. This result is confirmed bythe present study and others from Turkey
n et al. 10 Tahmaz et al. 15 Tuncel et al. 11 Kılıc et al. 3
43.6) 15 (34.9) 4 (26.7) 13 (46.4)
27.3) 6 (14.0) 4 (26.7) 8 (28.6)
3.6) 4 (9.3) - 1 (3.6)
10.9) - - 3 (10.7)
- - -
5.5) - - 1 (3.6)
3.6) 7 (16.3) - 1 (3.6)
5.5) - - 1 (3.6)
1 (2.3) 1 (6.7) -
6 (14.0) 3 (20) -
- 3 (20) -
4 (9.3) - -
- - -
e430 M. Ulug˘ et al.other published studies,7,14,21,22 except the study of Tuncel
et al.11 They stated that the index did not reflect the disease
severity and treatment outcome in their patients, howeverwe
claim that the FGSI is useful for predicting the outcome of FG.
FG is a rapidly progressive, fulminant infection. Its mor-
tality rate can be diminished by early diagnosis, aggressive
surgical intervention, and the use of broad-spectrum anti-
biotics. In our series, an unstable hemodynamic status at
presentation was an important factor that predicted poor
outcome. We found that diabetes mellitus and perianal
diseases were independent prognostic factors and that renal
dysfunction at admission was also an important risk factor for
FG. E. coli was the most common organism isolated from
patient wound cultures. The FGSI is an objective and simple
method to quantify the metabolic status and can be used
clinically to evaluate therapeutic options and assess results.
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